Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition
- DOI
- 10.1016/j.isci.2025.114088
- Published
- 2025-12
- Container
- iScience
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.isci.2025.114088,
title = {Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition},
author = {Susheel Kumar Nethi and Venugopal Gunda and Nagabhishek Sirpu Natesh and Brianna M. White and Adam S. Mullis and Balaji Narasimhan and Surinder K. Batra and Surya K. Mallapragada and Satyanarayana Rachagani},
year = {2025},
journal = {iScience},
doi = {10.1016/j.isci.2025.114088},
url = {https://doi.org/10.1016/j.isci.2025.114088}
}RIS
TY - JOUR TI - Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition AU - Susheel Kumar Nethi AU - Venugopal Gunda AU - Nagabhishek Sirpu Natesh AU - Brianna M. White AU - Adam S. Mullis AU - Balaji Narasimhan AU - Surinder K. Batra AU - Surya K. Mallapragada AU - Satyanarayana Rachagani PY - 2025 JO - iScience DO - 10.1016/j.isci.2025.114088 UR - https://doi.org/10.1016/j.isci.2025.114088 ER -
APA
Nethi, S. K., Gunda, V., Natesh, N. S., White, B. M., Mullis, A. S., Narasimhan, B., Batra, S. K., Mallapragada, S. K., & Rachagani, S. (2025). Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. iScience. https://doi.org/10.1016/j.isci.2025.114088
Source records
- crossref · retrieved 2026-09-26T00:58:58.259Z